[go: up one dir, main page]

CY2009010I2 - Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης - Google Patents

Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης

Info

Publication number
CY2009010I2
CY2009010I2 CY2009010C CY2009010C CY2009010I2 CY 2009010 I2 CY2009010 I2 CY 2009010I2 CY 2009010 C CY2009010 C CY 2009010C CY 2009010 C CY2009010 C CY 2009010C CY 2009010 I2 CY2009010 I2 CY 2009010I2
Authority
CY
Cyprus
Prior art keywords
alpha
pregna
epimer
dien
triol
Prior art date
Application number
CY2009010C
Other languages
English (en)
Other versions
CY2009010I1 (el
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7804358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2009010(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of CY2009010I2 publication Critical patent/CY2009010I2/el
Publication of CY2009010I1 publication Critical patent/CY2009010I1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
CY2009010C 1996-09-03 2009-07-24 Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης CY2009010I1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19635498A DE19635498A1 (de) 1996-09-03 1996-09-03 Verfahren zur Epimerenanreicherung
PCT/EP1997/004716 WO1998009982A1 (en) 1996-09-03 1997-08-29 Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione derivatives

Publications (2)

Publication Number Publication Date
CY2009010I2 true CY2009010I2 (el) 2010-07-28
CY2009010I1 CY2009010I1 (el) 2010-07-28

Family

ID=7804358

Family Applications (2)

Application Number Title Priority Date Filing Date
CY0400039A CY2454B1 (en) 1996-09-03 2004-05-18 Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11-beta-, 16.alpha.,17.alpha.-triol-3,20-dione derivatives.
CY2009010C CY2009010I1 (el) 1996-09-03 2009-07-24 Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY0400039A CY2454B1 (en) 1996-09-03 2004-05-18 Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11-beta-, 16.alpha.,17.alpha.-triol-3,20-dione derivatives.

Country Status (18)

Country Link
US (1) US6787533B1 (el)
EP (1) EP0929566B1 (el)
JP (1) JP3807509B2 (el)
AT (1) ATE229539T1 (el)
AU (1) AU736840B2 (el)
CA (1) CA2264863C (el)
CL (1) CL2004001297A1 (el)
CY (2) CY2454B1 (el)
CZ (1) CZ298789B6 (el)
DE (2) DE19635498A1 (el)
DK (1) DK0929566T3 (el)
EE (1) EE03927B1 (el)
ES (1) ES2188984T3 (el)
HU (1) HU228766B1 (el)
IL (1) IL128535A (el)
PL (1) PL186063B1 (el)
PT (1) PT929566E (el)
WO (1) WO1998009982A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
SK287545B6 (sk) * 2000-11-10 2011-01-04 Nycomed Gmbh Spôsob prípravy 16,17-[(cyklohexylmetylén)bis(oxy)]-11,21- dihydroxy-pregna-1,4-dién-3,20-diónu a podobných zlúčenín
DE10055820C1 (de) * 2000-11-10 2002-07-25 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung eines Glucocorticoids
WO2004033478A2 (en) 2002-10-08 2004-04-22 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
WO2004052374A1 (en) 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CN100345864C (zh) * 2004-10-29 2007-10-31 天津药业研究院有限公司 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
US20070135398A1 (en) * 2005-11-02 2007-06-14 Pierluigi Rossetto Process for the preparation of ciclesonide
JP2009526068A (ja) * 2006-02-08 2009-07-16 シコール インコーポレイティド シクレソニド結晶形
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
JP2010503722A (ja) 2006-09-19 2010-02-04 シプラ・リミテッド シクレソニドとその結晶変異体の調製方法
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
MX2010009303A (es) * 2008-03-13 2010-12-02 Farmabios Spa Proceso para la preparacion de derivados de pregnano.
US20100120737A1 (en) * 2008-11-10 2010-05-13 Martin Feth Amorphous ciclesonide
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
AU2017274442B2 (en) 2016-06-02 2021-08-19 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
WO2019106609A1 (en) 2017-12-01 2019-06-06 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
CN109293730A (zh) * 2018-10-23 2019-02-01 山东泰华生物科技股份有限公司 一种环索奈德的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
SE378110B (el) * 1972-05-19 1975-08-18 Bofors Ab
US3992534A (en) * 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8604059D0 (sv) * 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5482935A (en) 1993-01-05 1996-01-09 American Home Product Corporation Anti-atherosclerotic use of 17 alpha-dihydroequilin
ES2124884T3 (es) * 1993-04-02 1999-02-16 Byk Gulden Lomberg Chem Fab Nuevos derivados de prednisolona.
EP0749438B1 (de) 1994-03-09 2000-12-13 Byk Gulden Lomberg Chemische Fabrik GmbH Neue silylverbindungen und ihre verwendung

Also Published As

Publication number Publication date
AU736840B2 (en) 2001-08-02
AU4456797A (en) 1998-03-26
JP2000517330A (ja) 2000-12-26
EP0929566A1 (en) 1999-07-21
CL2004001297A1 (es) 2005-04-15
IL128535A (en) 2003-07-06
WO1998009982A1 (en) 1998-03-12
US6787533B1 (en) 2004-09-07
JP3807509B2 (ja) 2006-08-09
CZ72799A3 (cs) 1999-09-15
EE03927B1 (et) 2002-12-16
ATE229539T1 (de) 2002-12-15
CZ298789B6 (cs) 2008-01-30
CY2454B1 (en) 2005-06-03
EE9900079A (et) 1999-10-15
IL128535A0 (en) 2000-01-31
CA2264863C (en) 2007-07-31
HU228766B1 (hu) 2013-05-28
DE19635498A1 (de) 1998-03-26
PT929566E (pt) 2003-04-30
DE69717836D1 (de) 2003-01-23
CY2009010I1 (el) 2010-07-28
EP0929566B1 (en) 2002-12-11
ES2188984T3 (es) 2003-07-01
HUP9904127A2 (hu) 2000-04-28
HUP9904127A3 (en) 2001-02-28
CA2264863A1 (en) 1998-03-12
DE69717836T2 (de) 2003-09-18
PL186063B1 (pl) 2003-09-30
PL331699A1 (en) 1999-08-02
DK0929566T3 (da) 2003-04-07

Similar Documents

Publication Publication Date Title
CY2009010I1 (el) Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης
GB2247680B (en) Pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters
AU8946082A (en) 9lamda-chloro-11beba-hydroxy-16beta-methyl-17lamda,21- dipropionyl-oxypregna-1,4-diene-3,20-dione
DE10199030I1 (de) Substituierte Androsta-1, 4-dien-3, 17-dione und Verfahren zu deren Herstellung
FI874189L (fi) Epimeerisen jakaantumisen säätelymenetelmä pregnaanijohdannaisten 16,17-asetaalien valmistuksessa
ATA100797A (de) Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung
HUT61570A (en) Process for producing pregna-1,4-diene-3,20-dione derivatives
ATE204268T1 (de) Diarylmethylidenefuran-derivate, verfahren zu deren herstellung und ihre verwendungen in therapie
IL126539A (en) Pregnane derivatives with no alpha-17 substituent, their medicinal use and manufacturing method
SI0929566T1 (en) Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione derivatives
LV5274A3 (lv) 22(R,S)-11 beta,21-dihidroksi-16 alpha,17-butilidenbisoksipregna-1,4-dien-3,20-diona iegusanas panemiens
DK164478C (da) Anvendelse af 9alpha,11beta-dichlor-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion til fremstilling af et farmaceutisk praeparat til behandling af betaendelsestilstande i retcum eller colon
HU9902346D0 (en) New pregna-1,4-diene-3,20-dione derivatives
AR243198A1 (es) Procedimiento para la elaboracion de compuesto 9alfa-21-dihalogeno-11beta- hidroxi-17alfa-alcanoiloxi-6alfa-fluor-16beta-metilp regna-1,4-dien-3,20-diona
HU9503063D0 (en) New 16-(substituted methyl)-pregna-1,4-diene-3,20-dione derivatives and process for producing them
DE69739130D1 (de) 5-alkoxy-2(3h)-oxazolonderivate und verfahren zu ihrer herstellung
DE69521417D1 (de) Kapillarrohr und verfahren zu dessen herstellung
ZA919813B (en) Use of 2beta,16beta-diamino-3alpha,17-dihydroxy androstane derivatives
LV11102A (lv) Virushepatita ar holestazes sindromu diagnostikas metode
AR243199A1 (es) Procedimiento para elaborar compuestos de 9alfa,21-dihalogeno-llbeta- hidroxi-17alfa-alcanoiloxi-6alfa-fluor-16beta-metil- pregna-1,4-dien-3,20- diona
ITMI940613A0 (it) Procedimento per la preparazione di 17-idrossi-1-alfa, 2-alfa -metilenepregna-4, 6-dien-3,20-dione
DE3482574D1 (de) Verbundkoerper und verfahren zu dessen herstellung.
NO167294C (no) Fremgangsmaate for fremstilling av 16,17-acetal-substituerte steroider.